LOCALIZATION OF FREE AND BOUND SECRETORY COMPONENT IN HUMAN INTESTINAL EPITHELIAL CELLS : A MODEL FOR THE ASSEMBLY OF SECRETORY IgA by Poger, Marshall E. & Lamm, Michael E.
LOCALIZATION OF FREE AND  BOUND  SECRETORY  COMPONENT 
IN HUMAN  INTESTINAL EPITHELIAL  CELLS 
A  MODEL FOR TEE  ASSF.M~LY OF  SECRETORY IgA* 
BY MARSHALL E.  POGER  Am) MICHAEL E. LAMM$ 
(From the Department of Pathology, New York University School of Medicine, 
New York 10016) 
(Received for publication 12 November 1973) 
The  predominant  immunoglobulin  in  external  secretions  of  humans  and 
various other mammals is a special form of IgA known as secretory IgA (sIgA),  1 
a molecule composed of a  dimer of serum-type IgA plus a J  chain (in common 
with IgM) and a  distinctive polypeptide chain known as secretory component 
(SC)  (1-4).  Not only does SC occur in a  bound form (BSC)  as part of sIgA, 
but  a  portion is also present in  a  free form (FSC).  Recently,  FSC  and  BSC 
have been isolated from human and rabbit colostrum~ and the two forms com- 
pared by a  number of criteria. They are antigenically cross-reactive, indistin- 
guishable  by amino  acid  composition  and  size,  yield  similar  tryptic  peptide 
maps, and have identical N-terminal amino acid sequences (references 5-7 and 
footnote 2). However, we and others (8-10) have observed that in addition to 
common antigenic determinants, FSC has determinants not found in BSC, and 
vice versa. These antigenic differences, which are thought to be due to differences 
in the conformation of SC, have been utilized to quantitate FSC in the presence 
of BSC by immunoprecipitation (11). 
Histological localization of SC  (2,  12-19)  and a-chain,  the  heavy chain  of 
IgA  (2,  12,  13,  15,  19,  20),  in organs which  elaborate external secretions has 
been studied by immunofluorescence. For such work, antibody to SC has usually 
been obtained by absorbing antibodies to sIgA with serum-type IgA and normal 
human serum (NHS). By this means SC has been identified in the cytoplasm of 
epithelial cells in mucous membranes, spaces between these cells,  and secretions. 
* This investigation was supported bygrant  AI09738 from the National Institutes of Health. 
:~ Career Scientist of the Health Research Council of the City of New York under Contract 
1-474. 
x  Abbreviations used in this paper: APB-cellulose, (para-aminophenylbutyryl aminoethyl)- 
cellulose; BSC, bound secretory component; FITC, fluorescein isothiocyanate;  FSC, free 
secretory component; H  & E, hematoxylin and eosin; NCS, normal umbilical cord serum; 
NHS,  normal human  serum;  PBS, phosphate-buffered saline; SC,  secretory  component; 
sIgA, secretory IgA. 
Cunningham-Rundles, C.,  M.  E. Lamm, and  E. C. Franklin.  1974. Human secretory 
component. N-terminal  amino acid  sequences and peptide maps of  the form occurring in 
exocrine immunoglobulin  A and the free form. Manuscript submitted for publication. 
THE JOURNAL OF  EXPERIMENTAL MEDICINE • VOLUME 139,  1974  629 630  ASSEMBLY  OF  SECRETORY  IgA 
Also  by  immunofluorescence,  a-chains  have  been  described  in  plasma  cells 
adjacent  to mucosal  glands,  in epithelial  cells of some mucous membranes, in 
spaces between these cells, and in luminal secretions. Staining for J chain follows 
the same distribution  as a-chain (18). 
Current  hypotheses  on synthesis,  secretion,  and  assembly of sIgA  (12,  13) 
are based on immunofluorescence data and radioactive labeling experiments (2, 
21-25).  Serum-type IgA plus J  chain is thought to be synthesized and secreted 
locally bymucosal plasma cells, and then to diffuse across the epithelial basement 
membrane  into  spaces  between  overlying  epithelial  cells.  In  contrast,  SC  is 
thought  to be produced  by mucosal  epithelial  cells from which  it  is secreted 
into the spaces between these cells and the lumen of mucosal glands. However, 
the exact locus where  the  products  of the  two  types of cells  (plasma cell and 
epithelial cell) are combined to yield the fully assembled sIgA molecule  has not 
been  established.  There  are  several  possibilities.  First,  assembly  could  occur 
primarily extracellularly,  either in the  spaces between  mucosal epithelial  cells 
or in the lumen, which would be consistent with the assembly in vitro of sIgA 
from dimeric IgA and FSC  (26,  27).  Because  the  tight junctions  between  the 
apical portions of mucosal epithelial cells do not allow passage of large molecules 
into  glandular  lumens  (28),  it  has  been  suggested  that  sIgA,  previously  as- 
sembled in the  spaces  between  epithelial  cells,  could  reach  the  lumen  by tra- 
versing  the  apical  portion  of mucosal  epithelial  cells  (13).  Second,  assembly 
could occur at the epithelial cell membrane (29). A  third possibility is that the 
plasma cell products first enter the epithelial cell, in which complexing with SC 
takes place, to be followed by secretion of sIgA into the lumen. 
Previous  immunofluorescence  studies  have  not  utilized  antisera  capable  of 
distinguishing  between FSC  and BSC.  Consequently,  we decided  to study the 
cytological and histological distribution of FSC and BSC in human tissues with 
fuorescent  antibodies  rendered  specific for each of the  two forms of SC.  The 
results support a model in which final assembly occurs within the epithelial cell. 
Materials and Methods 
Antigens.--FSC  (6)  and  slgA  (7)  were isolated  from human colostrum,  and  were pure 
according to several immunologic and zone electrophoretic criteria. A human IgA1, K-myeloma 
protein (i.e., serum-type IgA) was isolated from ascitic fluid (provided by Dr. E. C. Franklin, 
New  York  University School of Medicine)  by starch  block  electrophoresis  (30). Normal 
human serum from several persons was pooled. Pooled normal cord serum (NCS) was obtained 
from fresh umbilical cord sera individually  shown to lack IgA on Ouchterlony  analysis. Human 
IgG was obtained from Schwarz/Mann Div., Becton,  Dickinson  & Co, Orangeburg,  N.  Y., 
and a purified human IgM myeloma protein was obtained from Dr. E. C.  Franklin. 
Antisera.--Anti-FSC,  anti-slgA and antimyeloma IgA were raised in rabbits (7). Animals 
being immunized with slgA received injections of rabbit antiserum to human serum-type IgA 
to suppress the antibody response to a- and L chains, and enhance  the antibody response  to 
BSC  (31). On immunoelectrophoresis  vs. whole colostrum,  b~th anfi-FSC (unabsorbed)  and 
anti-slgA (after absorption with serum-type IgA and NI~'S) showed only precipitin  lines due 
to FSC and BSC; these displayed partial identity. No other reactions with whom colostrum 
(or with purified lactoferrin,  a protein which tends  to contaminate preparations of SC  and 
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Absorption of Rntisera.--Antisera  were made specific for FSC, BSC, or a-chains by the use 
of solid  immunottdsorbents.  (Para-aminophenylbutyrylaminoethyl)cellulose  (APB-cellulose) 
was prepared and linked to the various protein antigens by diazotization (32).  Absorptions 
were accomplished by mixing the appropriate immunoadsorbent with antiserum (1 ml packed 
cellulose/4 ml whole serum) for 20 rain at room temperature, followed by removal of the ad- 
sorbent by eentrifugation. The supernate was then tested for completeness of absorption by  ~  ....... 
Ouchterlony a~ysls. Absorptaons  were repeated until unwanted precapxtataon  lines were no 
longer identified, and  then once more. From 2 to 4 absorptions were required for each anti- 
serum.  The final preparations  retained  strong  precipitating  activity for  the  antigenic de- 
terminants being selected. To obtain antiserum specific for FSC, the original anti-FSC anti- 
serum was absorbed with slgA-APB-cellulose. To obtain specific anti-BSC, anti-slgA antiserum 
was absorbed with a mixture of FSC-APB-cellulose, myeloma IgA-APB-cellulose, and NHS- 
APB-cellulose. Anti-o:-chain antiserum was prepared  by absorbing antimyeloma IgA serum 
with IgG-APB-cellulose and NCS-APB-cellulose. Further absorptions, indicated by the results 
of preliminary immunofluorescence studies were done in order to enhance the specificity of 
staining; these were accomplished by adding minute amounts of appropriate purified soluble 
antigens to the solid-absorbed immunoglobulins after coupling with fluoreseein (see below). 
Conjugation of A ntibody and Fluorescein.--After absorption of antisera with solid immuno- 
adsorbents,  the  IgG  fraction  was  isolated  by  DEAE-cellulose  chromatography  (0.01 M 
sodium phosphate  buffer,  pH 8.0),  shown  to be pure  by immunoelectrophoresis, and  con- 
centrated  to  about  10 mg/ml by  ultrafiltration.  Conjugation  to fluoreseein  isothiocyanate 
(FITC) was carried out using FITC adsorbed  to Celite (Calbiochem, La Jolla, Calif.)  (33). 
FITC on Celite (20 rag/100 mg IgG) was suspended in 0.5 M  sodium carbonate buffer, pH 
9.0 (volume equivalent to that of the IgG solution). The IgG was immediately added dropwise 
with stirring at room temperature. The pH remained constant,  and after 20 rain the Celite 
was removed by eentrifugation, and the supernate was passed through Sephadex G-25 (Phar- 
macia Fine Chemicals, Inc., Piscataway, N. J.) equilibrated in 0.0175  M  sodium phosphate 
buffer,  pH 6.3.  The fluoresceinated IgG was  then  chromatographed  on a  DEAE-cellulose 
column equilibrated  with  the  same  buyer.  Peaks  were  eluted  stepwise,  starting  with  the 
equilibrating buffer, followed by the addition of 0.15 M sodium chloride in the original buffer, 
and then 0.25 M sodium chloride in the original buffer (34). The major fraction of conjugated 
IgG was eluted in the 0.15 M sodium chloride fraction and had a molecular fluorescein/protein 
ratio  (35) of approximately 2. The purified conjugate was then ultrafiltered to 1 mg/ml for 
immunofluorescent staining.  Fluoreseeinated anti-FSC, anti-BSC, anti-cx-ehain,  and  normal 
rabbit IgG were prepared. 
Tissue Preparation.--Frozen  sections cut from  tissue  blocks  taken  from grossly normal 
areas of freshly removed surgical specimens were initially examined after staining with hema- 
toxylin and eosin (H  & E). Blocks showing normal histology were used for cutting multiple 
frozen sections, approximately 4 #m thick, which were mounted on glass slides  and kept at 
-- 10°C before fixation. 7 small intestines, 5 large intestines, 3 gallbladders, 4 salivary glands, 
and 10 bronchi were examined. 
For most of the studies, sections were fixed in acetone for 10 min before staining with fluores- 
cent antisera.  Unfixed and more lightly fixed sections were examined on occasion. Some sec- 
tions were fixed in absolute ethanol rather than acetone. Some tissue blocks were fixed in 10% 
neutral buffered formalin for 4 h  at 2-5°C followed by washing with  30%  sucrose  for  12 h 
before sectioning (13). 
Immunofluorescence.--The routine staining procedure consisted of wetting the sections in 
phosphate-buffered  saline  (PBS)  (0.15 M sodium chloride---0.01  M  sodium phosphate,  pH 
7.5) followed by staining with a drop of fluorescent antibody for 30 rain in a moist chamber. 
Sections were then dipped twice (5 rain each time) in PBS and  mounted in a glycerol-PBS 
mixture.  Fluorescent  antibody  preparatibns  employed  included  anti-FSC,  anti-BSC,  and 
anti-o-chain reagents. 
Sections were examined with a  Leitz Diahix fluorescence microscope equipped with an 632  ASSEMBLY OF  SECRETORY IgA 
Osram HBO 200 high pressure mercury vapor light source, BG 12 excitation filter, BG 38 sup- 
pression filter,  and a  K  530 barrier filter (E. Leitz, Inc., Rockleigh, N. J.). Controls included: 
blocking, in which the section was treated with unconjugated antiserum before staining with 
the same antibody in conjugated form; absorption of antibody reagents with the purified 
homologous antigen in soluble form after antibody conjugation with FITC; and staining with 
fluoresceinated normal rabbit IgG. 
Specificity of Fluorescent Antibodies.--Before  conjugation with FITC, anti-FSC and anti- 
BSC had been absorbed with solid immunoadsorbents until anti-FSC no longer precipitated 
sIgA and anti-BSC no longer precipitated FSC or serum-type IgA or Ouchterlony analysis. 
To evaluate whether this specificity persisted on immunofluorescence  analysis, frozen sections 
of small bowel were treated with solid-absorbed  fluoresceinated  anti-FSC and anti-BSC. Both 
preparations stained the cytoplasm of columnar epithelial cells of mucosal glands, most promi- 
nently in the apical region and the supranuclcar Golgi zone. Anti-BSC also stained plasma 
cells in the lamina propria. The qualitative similarity in the staining of epithelial cells by these 
two antibody preparations did not distinguish between the following two possibilities: an 
overlap in the distribution of FSC and BSC, or a lack of specificity.  However, the staining of 
plasma cells by the anti-BSC preparation was evidence that the specificity  obtained, using 
Ouchterlony analysis as a criterion, was not necessarily valid for immunofluorescence. There- 
fore, further absorptions of solid-absorbed fluoresceinated anti-FSC and anti-BSC were done 
with purified soluble antigens to increase the specificity of the fluorescence. 
Anti-FSC:  In  case  solid-absorbed  anti-FSC  still  cross-reacted  with  BSC,  a  minute 
amount of soluble slgA was added. Immunofluorescence staining of small bowel sections then 
showed loss of the prominent apical cytoplasmic staining of epithelial cells but intense staining 
of the Golgi area persisted. This reagent was considered specific for FSC and was used in the 
ensuing studies. 
Anti-BSC:  Anti-BSC, treated  with solid  immunoadsorbent, still reacted  on immuno- 
fluorescence with serum-type IgA (i.e., plasma cells) and might also have reacted slightly with 
FSC because it stained the Golgi zone weakly. The addition of soluble IgG and myeloma IgA 
to this antibody preparation abolished the fluorescence  of plasma cells; however,  prominent 
apical cytoplasmic staining persisted, as did weak Golgi zone staining. Because this reagent 
stained the apical cytoplasm of columnar gland cells  strongly, but stained the  Golgi zone 
(shown by the anti-FSC reagent to be the principal locus of FSC) only weakly, it was used in 
the ensuing immunofluorescence  studies to detect BSC.  a 
Anti-a-chain:  Antimyeloma IgA was treated with solid immunoadsorbents to be specific 
for or-chains  by double diffusion analysis. To evaluate specificity,  frozen sections of small 
bowel were  examined. Specific staining was limited to mucosal plasma cells and the apical 
cytoplasm of columnar cells of mucosal glands. Further absorptions carried out by adding 
minute amounts of pure soluble IgG and IgM to the anti-o~-chain preparation produced only 
a slight decrease  in staining intensity and no change of pattern. This latter reagent was con- 
sidered  to be specific for a-chains on immunofluorescence analysis, and was used in the fol- 
lowing studies. 
RESULTS 
Small  Intestine.--The  various  specimens  showed  almost  identical  staining 
patterns.  Anti-FSC  stained  the  cytoplasm  of  mucosal  columnar  cells  (both 
crypts and villi) most prominently in the supranuclear Golgi zone (Fig. 1). Both 
anti-or and anti-BSC prominently stained the luminal border of columnar cells 
3 It was not possible to improve the specificity  of the anti-BSC reagent by adding both 
soluble-myeloma IgA and soluble FSC. When this was attempted all staining, including the 
apical cytoplasm where BSC predominates, disappeared, probably because the soluble FSC 
and IgA had combined (26, 27) to produce effectively sIgA, and hence BSC. MARSHALL  E.  POGER  AND  MICffAEL  E.  LAMM  633 
in mucosal crypts (Figs. 2 and 3) ; no staining of villous epithelial cells was seen. 
The staining for [ SC  and a-chains,  which  sometimes showed linear,  radially 
or/ented striations, was identical and had a variable depth measuring from 3 to 
5 ~m. This distribution  correlates partially with  the location of microvilli on 
the  luminal  surface  of  crypt  epithelial  cells  (36),  but  since  small  intestinal 
m'.'crovilli  measure only about  1 #m in height  (reference 37  and footnote 4), 
sIgA is most probably located not only in the region of the microvilli but also in 
a zone of underlying apical cytoplasm. 
No staining of goblet cells for FSC, BSC, or a-chains was seen, a result which 
can be attributed  to the high degree of specificity of our antisera.  The inter- 
epithelial cell spaces, which could be identified above the nucleus, consistently 
did not stain for FSC, BSC, or a-chains, a-chains, without SC, were prominent 
in many lamina propria plasma cells,  both in villous cores and  about crypts 
(Fig. 3). 
Colon.--The  colonic mucosal crypts are composed mainly of mucous-filled 
goblet cells between which may be columnar cells,  either isolated or in groups. 
All specimens of colon showed identical staining. FSC was found predom:nantly 
in the supranucleat  Golgi zone of columnar crypt cells (Fig. 4 a), similar to its 
location in  the small bowel, sIgA, identified  by the simultaneous presence of 
BSC and a-chains, was seen throughout the apical half of the columnar crypt 
cell cytoplasm in a granular distribution which was most dense at the luminal 
surface and decreased in density deeper into the cytoplasm (Figs. 4 b and 5). 
a-chains were also found in numerous plasma cells of the lamina propria (Fig. 5). 
No goblet cell staining was seen. 
To identify interepithelial cell spaces in colonic mucosa is more difficult than 
in small bowel because of the large number of goblet cells among which there 
may be isolated columnar cells. Thin frozen sections are required since staining 
of such individual columnar cells can easily be mistaken for staining of an inter- 
cellular  space  (Fig.  6).  Our  interpretations,  accordingly,  are  based  on  areas 
containing  groups of two or more columnar cells between goblet cells.  As in 
small bowel, intercellular spaces could only be identified above the nucleus. We 
were unable to identify FSC, 13SC and a-chains in intercellular spaces. 
Other Organs.--In the gallbladder mucosa, FSC was present in the cytoplasm 
of the columnar surface epithelial  cells in  a  finely granular pattern  (Fig.  7). 
sIgA could not be identified  since  neithm  anti-BSC  nor anti-a-chain reagent 
stained the mucosa, which is consistent with the rare occurrence of plasma cells 
in H  & E-stained sections. Interepithelial cell spaces did not stain for FSC. 
The bronchial  glands and  the  salivary glands contain  acini  which  may be 
serous, mucous, or mixed. The serous cells consistently stained for SC whereas 
the mucous cells were uniformly negative (Fig. 8). 
4 The height of the microvilli  within small intestinal crypts in our specimens  was confirmed 
in electron micrographs, which were kindly done by Dr. D. Sabatini, New York University 
School of Medicine. 634 MARSHALL  E.  POGER  AND  MICHAEL  E.  LAMM  635 
DISCUSSION 
The object of these studies was to investigate the histological and cytological 
distribution  of BSC  vs. FSC,  which necessitated  reagents  which  were  specific 
for SC,  and able to discriminate between the bound  and free forms. The anti- 
sera to be used to prepare the fluorescent reagents were initially absorbed with 
solid  immunoadsorbents,  which  rendered  them  specific  by  the  criterion  of 
Ouchterlony analysis but not completely specific by the more sensitive criterion 
of immunofluorescence. A possible explanation for this result is that the antigen 
is  joined  to  the  adsorbent  by  a  diazonium  bond,  which  utilizes  principally 
tyrosine residues in the antigen, thus blocking certain antigenic sites and making 
it impossible to achieve complete absorption with a solid adsorbent alone. What- 
ever  the  reason,  the  subsequent  addition  of a  small  amount  of pure  soluble 
antigen afforded a more complete absorption such that anti-FSC  and anti-BSC 
stained different regions of the cytoplasm of the columnar cells of the large and 
small  bowel.  Even  without  absorption,  the  anti-FSC  and  anti-BSC  reagents 
did  not  stain  mucosal  goblet  cells  in  the  intestines.  The  lack  of mucous  cell 
staining was not limited to the intestines since the bronchial glands and salivary 
glands,  which  consistently  showed  SC  in  the  cytoplasm of the  epithelial  cells 
lining serous acini, did not show staining in mucous acini. 
The  prominent  Golgi zone  staining  for  FSC  that  we  obselved  in mucosal 
columnar  epithelial  cells of large and  small  bowel has not  been reported pre- 
viously. The reason for this is not clear. One possibility is related to the method 
of fixation. For example, we found that with formaldehyde or absolute ethanol 
Golgi staining was not apparent. It is also likely that our antisera are somewhat 
different  from  those  used  by  others.  Most  preceding  immunofluorescence 
studies,  in  which  SC  was  observed  predominantly  in  the  apical  portions  of 
epithelial  cells, have utilized  antisera to sIgA rather than to FSC. These anti- 
sera  have  been  absorbed  to  react  only with  SC,  both  bound  and  free,  but 
probably more with  bound.  In contrast,  our  antisera  vs.  sIgA were  obtained 
from rabbits which also received antiserum  to serum-type IgA (31);  after ab- 
sorption with serum-type IgA and IgG they stained  the  Golgi zone as well as 
the apical cytoplasm of columnar cells. In addition to antiserum raised against 
Fla.  1.  Human small intestinal mucosa  treated with fluorescent  anti-FSC.  (a) At low 
magnification (X 160) FSC can be seen in the cytoplasm of columnar epithelial cells of crypts 
(below) and villi (above). Staining is most intense in the supranuclear  Golgi zone (see also 1 b 
and 1 c). (b and c) Higher magnification (X 760) of epithelium in crypts and villi, respectively, 
showing that FSC is most concentrated in the supranuclear  Golgi zone. Goblet cells (g) and 
intercellular  spaces (arrowheads),  where identifiable, do not contain FSC. The letter L in 1 c 
denotes the intestinal lumen between adjacent villi. Staining in the lamina propria (blue in the 
original) is nonspecific. 
Fio. 2.  Human small intestinal mucosa treated with fluorescent anti-BSC. BSC is present 
in the apical cytoplasm of columnar epithelial cells lining the crypts, and is absent from the 
Golgi zone and goblet cells (g). X 760. 636 MARSHALL E.  POGER AND MICHAEL E.  LAMM  637 
sIgA, we also employed antiserum raised against purified FSC, and this latter 
yielded the most prominent Golgi staining. 
The Golgi apparatus is known to participate in the synthesis and packaging 
for secretion of complex mucoproteins after protein synthesis has taken place 
in the  adjacent rough surfaced endoplasmic reticulum  (38,  39).  Thus,  in  the 
small and large bowel the presence of FSC principally in the Golgi zone offers 
additional  evidence beyond the mere presence of SC in epithelial  cells that SC 
is in fact synthesized de novo in columnar epithelial cells. 
The IgA portion of sIgA is synthesized by local plasma cells. Although the 
formation of sIgA therefore requires  the synthesis of appropriate  subunits  by 
two distinct types of cell, it is probable that the production of SC by epithelial 
cells and the local production of IgA by plasma cells are not directly interde- 
pendent.  For  example,  FSC  can  be  produced  by epithelial  cells  without  as- 
sociated  IgA production  in  plasma  cells  as  seen  in  the  mucosa  of  the  gall- 
bladder  and  also  in  nonlactating  young  adult  female  breast  (M.  E.  Poger, 
unpublished  data).  Furthermore,  agammaglobulinemic  persons  and  newborn 
infants synthesize and secrete FSC (21). 
The identification of BSC in the apical cytoplasm of columnar crypt cells of 
colon and small bowel is consistent with the staining of the same regions with 
anti-a-chain reagents. Other studies have shown a similar intracellular staining 
pattern  for a-chains  (12-14,  18, 40).  Thus,  BSC  and a-chain  (i.e.,  sIgA) are 
present  in the apical  cytoplasm of the same cell which synthesizes SC.  These 
observations favor a model in which the assembly of sIgA occurs intracellularly 
after FSC is concentrated in the Golgi area. The granular distribution  of BSC 
which  increases  in  prominence  in  the  apical  cytoplasm  toward  the  luminal 
border  (especially in  the  colon)  is  consistent  with  the  current  model  for the 
elaboration of numerous external secretions in which the secretion product, after 
leaving the Golgi zone, is increasingly concentrated in granules which move to- 
FIG. 3.  Human small intestinal  mucosa treated  with fluorescent anti-o~-chain. (a) Low 
magnification (X 160) showing villi (upper right) and crypts (lower left), a-chains are seen at 
the luminal  borders of epithelial  cells lining the crypts; they are absent  from  the villous 
epithelium, a-chains also are present in numerous plasma cells within  the lamina  propria  of 
both villi and crypts. The staining pattern with anti-BSC is identical except that there is no 
fluorescence due to plasma cells in the lamina propria.  (b) Higher magnification (X 760) of 
crypts, a-chains are prominent in the apical cytoplasm of columnar epithelial cells (compare 
with the location of BSC in Fig. 2). Goblet cells (g) do not contain a-chains.  The fluorescence 
in the lamina propria is due to plasma cells. 
FIG. 4.  Crypts in human colonic mucosa. (a) Treated  with fluorescent anti-FSC.  FSC is 
located in the cytoplasm of columnar epithelial cells and is absent from goblet cells (g). As 
in the small intestine, FSC is most concentrated in the supranuclear  Golgi zone. The fluores- 
cence in the lamina propria  is nonspeciflc, (X  760). (b) Treated with fluorescent anti-BSC. 
BSC is most prominent in the apical half of the cytoplasm of columnar epithelial cells where it 
is distributed in a granular fashion; there is no accentuation of the Golgi zone. BSC is absent 
from goblet cells (g). The intercellular spaces (arrowhead) do not fluoresce. X 860. 638 MARSHALL E.  POGER AND MICHAEL E.  LAMM  639 
ward the luminal surface where they are discharged (41, 42). The point of entry 
of a-chains into  the epithelial cell and  the exact intracellular location where 
assembly of sIgA occurs have still to be determined. With immunofluorescence 
we are probably only identifying zones where FSC, BSC, and a-chains are con- 
centrated. The most direct interpretation of our data is that assembly occurs 
in the supranuclear Golgi zone or in the adjacent apical cytoplasm. 
SUMMARY 
Antibody reagents were made specific for each of the two forms of human 
SC,  FSC and BSC,  which is an integral part of the slgA molecule. With the 
fuorescent  antibody  method  the  cytological and  histological  localization of 
FSC,  BSC,  and  a-chains has  been  studied  in  various  human  mucous  mem- 
branes. SC was present in columnar epithelial cells of the intestines and in the 
cells of serous acini of bronchial and salivary glands. In contrast, SC was not 
found in intestinal goblet cells or cells of mucous acini of bronchial and salivary 
glands. In the columnar epithelial cells of the small and large bowel, FSC was 
present most prominently in the Golgi zone, and much less prominently in the 
apical cytoplasm. On the other hand,  BSC  and a-chains were located only in 
the apical cytoplasm in an overlapping manner.  The results favor a  model in 
which slgA is assembled inside epithelial cells from SC, which was synthesized 
in the same cell, and IgA, which  entered  the epithelial cell after synthesis in 
and secretion by a plasma cell. 
We wish to thank Dr.  Gloria Gallo for her interest and for the use  of her fluorescence 
microscope. 
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FIG. 5.  Crypt in human colonic mucosa treated with fluorescent anti-a-chain, a-chains 
fluoresce in a granular fashion in the apical cytoplasm, similar to the distribution of BSC in 
Fig. 4 b. The bracket encloses several columnar cells. Goblet cells (g) are negative. Numerous 
plasma cells in the lamina propria stain for a-chains. X  760. 
FIQ. 6.  Crypts in colonic mucosa treated with fluorescent anti-BSC. Columnar epithelial 
cells in groups can be identified between goblet cells (e.g., the three bracketed cells). Single 
columnar cells between  goblet cells (arrowheads),  on the other hand, can be confused with 
intercellular spaces. >( 860. 
FIG. 7.  Human gallbladder mucosa treated with fluorescent anti-FSC. FSC is located in 
the cytoplasm of the surface columnar epithelial cells; intercellular spaces  (arrowhead)  are 
negative. L denotes lumen.  X  760. 
FIG. 8.  Human bronchial glands treated with fluorescent anti-SC. Serous acini contain SC 
in the cytoplasm of the epithelial cells. SC is not present in mucous acini (M).  X 400. 640  ASSEMBLY OF  SECRETORY IgA 
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